Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 23913469)

1.

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Bucciarelli P, De Stefano V, Passamonti SM, Tormene D, Legnani C, Rossi E, Castaman G, Simioni P, Cini M, Martinelli I.

Blood. 2013 Oct 10;122(15):2555-61. doi: 10.1182/blood-2013-05-503649. Epub 2013 Aug 2.

2.

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.

Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG.

CMAJ. 2013 Mar 19;185(5):E229-37. doi: 10.1503/cmaj.121636. Epub 2013 Feb 4.

3.

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB.

JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853. Review.

PMID:
19531787
4.

In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.

Rossi E, Ciminello A, Za T, Betti S, Leone G, De Stefano V.

Thromb Haemost. 2011 Oct;106(4):646-54. doi: 10.1160/TH11-02-0080. Epub 2011 Aug 11.

PMID:
21833444
5.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

6.

Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.

Saemundsson Y, Sveinsdottir SV, Svantesson H, Svensson PJ.

J Thromb Thrombolysis. 2013 Oct;36(3):324-31. doi: 10.1007/s11239-012-0824-5.

PMID:
23054468
7.

Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.

Cordoba I, Pegenaute C, González-López TJ, Chillon C, Sarasquete ME, Martin-Herrero F, Guerrero C, Cabrero M, Garcia Sanchez MH, Pabon P, Lozano FS, Gonzalez M, Alberca I, González-Porras JR.

Eur J Haematol. 2012 Sep;89(3):250-5. doi: 10.1111/j.1600-0609.2012.01809.x. Epub 2012 Jun 29.

PMID:
22642978
8.

Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.

Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A.

Croat Med J. 2001 Aug;42(4):488-92.

9.

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.

Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.

PMID:
18796457
10.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C.

Chest. 2009 Dec;136(6):1537-45. doi: 10.1378/chest.09-0757. Epub 2009 Jul 10.

PMID:
19592474
11.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
13.

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

Sveinsdottir SV, Saemundsson Y, Isma N, Gottsäter A, Svensson PJ.

Thromb Res. 2012 Sep;130(3):467-71. doi: 10.1016/j.thromres.2012.03.020. Epub 2012 Apr 17.

PMID:
22512897
14.

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.

Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):471-6. doi: 10.1097/MBC.0b013e32835e4260.

PMID:
23358226
15.

Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.

Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M.

Neuro Endocrinol Lett. 2007 Oct;28(5):699-703.

PMID:
17984931
16.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.

Haematologica. 2001 Nov;86(11):1200-8.

17.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

18.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

PMID:
18217158
19.

Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.

Couturaud F, Kearon C, Leroyer C, Mercier B, Abgrall JF, Le Gal G, Lacut K, Oger E, Bressollette L, Ferec C, Lamure M, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2006 Dec;96(6):744-9.

PMID:
17139368
20.

Factors that predict thrombosis in relatives of patients with venous thromboembolism.

Couturaud F, Leroyer C, Tromeur C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C.

Blood. 2014 Sep 25;124(13):2124-30. doi: 10.1182/blood-2014-03-559757. Epub 2014 Jul 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk